News Release

Mechanism underlying the ability of H3 receptor antagonist to treat brain edema

Peer-Reviewed Publication

Neural Regeneration Research

Pup

image: This is levorotation in a pup subjected to surgery and hypoxia, indicating a successful neonatal hypoxic-ischemic encephalopathy model in rat pup. view more 

Credit: <i>Neural Regeneration Research</i>

Thioperamide, a selective histamine H3 receptor antagonist, can increase histamine content in the brain and improve brain edema in adult hypoxic rats. Brain edema is precisely considered as the important pathological change of neonatal hypoxic-ischemic encephalopathy. As a study reported in the Neural Regeneration Research (Vol. 8, No. 19, 2013), thioperamide was used to increase histamine content in the brain, and then the mechanism of action of thioperamide during brain edema in a rat model of neonatal hypoxic-ischemic encephalopathy was examined. Results showed that thioperamide significantly decreased brain water content and malondialdehyde levels, while significantly increased histamine levels and su-peroxide dismutase activity in the hippocampus. This evidence demonstrates that thioperamide could prevent oxidative damage and attenuate brain edema following neonatal hypoxic-ischemic encephalopathy. The researchers further found that the H1 receptor antagonist, pyrilamine, reversed the effects of thioperamide; however, the H2 receptor antagonist, cimetidine, had no significant influence on the effects of thioperamide. The researchers suggest that thioperamide can increase brain histamine content and attenuate brain edema and oxidative damage by acting in combination with postsynaptic H1 receptors in a rat model of neonatal hypoxic-ischemic encephalopathy.

###

Article: " Thioperamide treats neonatal hypoxic-ischemic encephalopathy by postsynaptic H1 receptors " by Feiyong Jia, Lin Du, Yunpeng Hao, Shicheng Liu, Ning Li, Huiyi Jiang (Division of Pediatric Neurorehabilitation, Department of Pediatrics, Second Part of First Hospital of Jilin University, Changchun 130031, Jilin Province, China)

Jia FY, Du L, Hao YP, Liu SC, Li N, Jiang HY. Thioperamide treats neonatal hypoxic-ischemic encephalopathy by postsynaptic H1 receptors. Neural Regen Res. 2013;8(19):1814-1822.

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
http://www.nrronline.org/

Full text: http://www.sjzsyj.org:8080/Jweb_sjzs/CN/article/downloadArticleFile.do?attachType=PDF&id=652


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.